{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:55Z","timestamp":1777984315998,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG058503-01A1"],"award-info":[{"award-number":["T32AG058503-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG063808"],"award-info":[{"award-number":["R01AG063808"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01RX003224"],"award-info":[{"award-number":["I01RX003224"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS131110"],"award-info":[{"award-number":["RF1NS131110"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["19CVD01"],"award-info":[{"award-number":["19CVD01"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00767-9","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:16:50Z","timestamp":1769599010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["2-Hydroxypropyl-\u03b2-cyclodextrin accesses acute and subacute infarcts in a mouse model of ischemic stroke"],"prefix":"10.1186","volume":"23","author":[{"given":"Danielle A.","family":"Becktel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan A.","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick G.","family":"Schnellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian P.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"767_CR1","doi-asserted-by":"publisher","unstructured":"Martin SS et al. Feb., \u20182024 Heart disease and stroke statistics: a report of US and global data from the American heart association\u2019, Circulation, vol. 149, no. 8, pp. E347\u2013E913, 2024, https:\/\/doi.org\/10.1161\/CIR.0000000000001209","DOI":"10.1161\/CIR.0000000000001209"},{"key":"767_CR2","doi-asserted-by":"publisher","unstructured":"Lakhan SE, Kirchgessner A, Hofer M. \u2018Inflammatory mechanisms in ischemic stroke: Therapeutic approaches\u2019, J Transl Med, vol. 7, no. 1, pp. 1\u201311, Nov. 2009, https:\/\/doi.org\/10.1186\/1479-5876-7-97\/FIGURES\/4","DOI":"10.1186\/1479-5876-7-97\/FIGURES\/4"},{"key":"767_CR3","doi-asserted-by":"publisher","unstructured":"Brott T, Bogousslavsky J. \u2018Treatment of acute ischemic stroke\u2019, New England Journal of Medicine, vol. 343, no. 10, pp. 710\u2013722, Sep. 2000, https:\/\/doi.org\/10.1056\/NEJM200009073431007","DOI":"10.1056\/NEJM200009073431007"},{"key":"767_CR4","doi-asserted-by":"publisher","unstructured":"van der Worp HB, van Gijn J. \u2018Acute ischemic stroke\u2019, New England Journal of Medicine, vol. 357, no. 6, pp. 572\u2013579, Aug. 2007, https:\/\/doi.org\/10.1056\/NEJMcp072057","DOI":"10.1056\/NEJMcp072057"},{"key":"767_CR5","doi-asserted-by":"publisher","unstructured":"Ciccone A et al. Mar., \u2018Endovascular treatment for acute ischemic stroke\u2019, New England Journal of Medicine, vol. 368, no. 10, pp. 904\u2013913, 2013, https:\/\/doi.org\/10.1056\/NEJMoa1213701","DOI":"10.1056\/NEJMoa1213701"},{"key":"767_CR6","doi-asserted-by":"publisher","unstructured":"\u2018Acute Ischemic Stroke: Imaging and Intervention\u2019, AJNR Am J Neuroradiol, vol. 28, no. 8, p. 1622. Sep. 2007, https:\/\/doi.org\/10.3174\/AJNR.A0628","DOI":"10.3174\/AJNR.A0628"},{"key":"767_CR7","doi-asserted-by":"publisher","unstructured":"Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. Nov. 2020;48(11):1654. https:\/\/doi.org\/10.1097\/CCM.0000000000004597.","DOI":"10.1097\/CCM.0000000000004597"},{"key":"767_CR8","doi-asserted-by":"publisher","unstructured":"Braga SS. \u2018Cyclodextrins: Emerging Medicines of the New Millennium\u2019, Biomolecules 2019, Vol. 9, Page 801, vol. 9, no. 12, p. 801, Nov. 2019. https:\/\/doi.org\/10.3390\/BIOM9120801","DOI":"10.3390\/BIOM9120801"},{"key":"767_CR9","doi-asserted-by":"publisher","unstructured":"Pontikis CC, Davidson CD, Walkley SU, Platt FM, Begley DJ. Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability. J Inherit Metab Dis. May 2013;36(3):491\u20138. https:\/\/doi.org\/10.1007\/S10545-012-9583-X\/FIGURES\/5.","DOI":"10.1007\/S10545-012-9583-X\/FIGURES\/5"},{"key":"767_CR10","doi-asserted-by":"publisher","unstructured":"Coisne C, Tilloy S, Monflier E, Wils D, Fenart L, Gosselet F. \u2018Cyclodextrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenerative diseases\u2019, Molecules, vol. 21, no. 12, Dec. 2016, https:\/\/doi.org\/10.3390\/MOLECULES21121748","DOI":"10.3390\/MOLECULES21121748"},{"key":"767_CR11","doi-asserted-by":"publisher","unstructured":"Zimmer S, et al. Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming. Sci Transl Med. 2016;8(333). https:\/\/doi.org\/10.1126\/scitranslmed.aad6100.","DOI":"10.1126\/scitranslmed.aad6100"},{"key":"767_CR12","doi-asserted-by":"publisher","unstructured":"Braga SS. \u2018Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases\u2019, Biomolecules, vol. 13, no. 4, Apr. 2023, https:\/\/doi.org\/10.3390\/biom13040666","DOI":"10.3390\/biom13040666"},{"key":"767_CR13","doi-asserted-by":"publisher","unstructured":"Becktel DA, et al. Repeated administration of 2-Hydroxypropyl-\u03b2-Cyclodextrin (HP\u03b2CD) attenuates the chronic inflammatory response to experimental stroke. J Neurosci. Jan. 2022;42(2):325\u201348. https:\/\/doi.org\/10.1523\/JNEUROSCI.0933-21.2021.","DOI":"10.1523\/JNEUROSCI.0933-21.2021"},{"issue":"1","key":"767_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneumeth.2012.03.003","volume":"207","author":"KP Doyle","year":"2012","unstructured":"Doyle KP, Fathali N, Siddiqui MR, Buckwalter MS. Distal hypoxic stroke: A new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit. J Neurosci Methods. 2012;207(1):31\u201340. https:\/\/doi.org\/10.1016\/j.jneumeth.2012.03.003.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"767_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40478-016-0371-y","volume":"4","author":"TVV Nguyen","year":"2016","unstructured":"Nguyen TVV, et al. Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue. Acta Neuropathol Commun. 2016;4(1):100. https:\/\/doi.org\/10.1186\/s40478-016-0371-y.","journal-title":"Acta Neuropathol Commun"},{"key":"767_CR16","doi-asserted-by":"publisher","unstructured":"Je KH, et al. Green-channel autofluorescence imaging: a novel and sensitive technique to delineate infarcts. J Neurosci Methods. Mar. 2017;279:22\u201332. https:\/\/doi.org\/10.1016\/J.JNEUMETH.2017.01.007.","DOI":"10.1016\/J.JNEUMETH.2017.01.007"},{"key":"767_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02387-8","author":"J Gaspar","year":"2017","unstructured":"Gaspar J, Mathieu J, Alvarez P. 2-Hydroxypropyl-beta-cyclodextrin (HP\u03b2CD) reduces age-related Lipofuscin accumulation through a cholesterol-associated pathway. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-02387-8.","journal-title":"Sci Rep"},{"key":"767_CR18","doi-asserted-by":"publisher","unstructured":"Gidwani B, Vyas A. \u2018A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer Drugs\u2019, 2015. https:\/\/doi.org\/10.1155\/2015\/198268","DOI":"10.1155\/2015\/198268"},{"key":"767_CR19","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.0808-05","author":"A Rasheed","year":"2008","unstructured":"Rasheed A, Kumar A C.K., and, Sravanthi VVNSS. \u2018Cyclodextrins as Drug Carrier Molecule: Review\u2019. 2008. https:\/\/doi.org\/10.3797\/scipharm.0808-05.","journal-title":"\u2018Cyclodextrins as Drug Carrier Molecule: Review\u2019"},{"key":"767_CR20","doi-asserted-by":"publisher","unstructured":"Kalydi E, Malanga M, Nielsen TT, Wimmer R, B\u00e9ni S. Solving the puzzle of 2-hydroxypropyl \u03b2-cyclodextrin: detailed assignment of the substituent distribution by NMR spectroscopy. Carbohydr Polym. Aug. 2024;338:122167. https:\/\/doi.org\/10.1016\/J.CARBPOL.2024.122167.","DOI":"10.1016\/J.CARBPOL.2024.122167"},{"key":"767_CR21","doi-asserted-by":"publisher","unstructured":"Gould S, Scott RC. \u20182-Hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD): a toxicology review\u2019, 2005. https:\/\/doi.org\/10.1016\/j.fct.2005.03.007","DOI":"10.1016\/j.fct.2005.03.007"},{"issue":"12","key":"767_CR22","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1023\/A:1015929720063\/METRICS","volume":"7","author":"HW Frijlink","year":"1990","unstructured":"Frijlink HW, Visser J, Hefting NR, Oosting R, Meijer DKF, Lerk CF. The pharmacokinetics of \u03b2-Cyclodextrin and Hydroxypropyl-\u03b2-cyclodextrin in the rat. Pharm Research: Official J Am Association Pharm Scientists. 1990;7(12):1248\u201352. https:\/\/doi.org\/10.1023\/A:1015929720063\/METRICS.","journal-title":"Pharm Research: Official J Am Association Pharm Scientists"},{"key":"767_CR23","doi-asserted-by":"publisher","unstructured":"Loftsson T, Brewster ME. \u2018Pharmaceutical applications of cyclodextrins: basic science and product development\u2019, Journal of Pharmacy and Pharmacology, vol. 62, no. 11, pp. 1607\u20131621, Nov. 2010, https:\/\/doi.org\/10.1111\/J.2042-7158.2010.01030.X","DOI":"10.1111\/J.2042-7158.2010.01030.X"},{"key":"767_CR24","doi-asserted-by":"publisher","unstructured":"Kao ML, et al. Pharmacokinetics and distribution of 2-hydroxypropyl-\u03b2-cyclodextrin following a single intrathecal dose to cats. J Inherit Metab Dis. 2020;43. https:\/\/doi.org\/10.1002\/jimd.12189.","DOI":"10.1002\/jimd.12189"},{"key":"767_CR25","doi-asserted-by":"publisher","unstructured":"Ory DS et al. Oct., \u2018Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1\u20132 trial\u2019, The Lancet, vol. 390, no. 10104, pp. 1758\u20131768, 2017, https:\/\/doi.org\/10.1016\/S0140-6736(17)31465-4","DOI":"10.1016\/S0140-6736(17)31465-4"},{"key":"767_CR26","doi-asserted-by":"publisher","unstructured":"V\u00e1radi J et al. Oct., \u2018Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin\u2019, Biomolecules, vol. 9, no. 10, 2019, https:\/\/doi.org\/10.3390\/BIOM9100509","DOI":"10.3390\/BIOM9100509"},{"key":"767_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.01.007","author":"JC Zbesko","year":"2018","unstructured":"Zbesko JC, et al. Glial scars are permeable to the neurotoxic environment of chronic stroke infarcts. Neurobiol Dis. 2018. https:\/\/doi.org\/10.1016\/j.nbd.2018.01.007.","journal-title":"Neurobiol Dis"},{"key":"767_CR28","doi-asserted-by":"publisher","unstructured":"Chung AG et al. \u2018Liquefaction of the brain following stroke shares a similar molecular and morphological profile with atherosclerosis and mediates secondary neurodegeneration in an osteopontin-dependent mechanism\u2019, eNeuro, vol. 5, no. 5, 2018, https:\/\/doi.org\/10.1523\/ENEURO.0076-18.2018","DOI":"10.1523\/ENEURO.0076-18.2018"},{"key":"767_CR29","doi-asserted-by":"publisher","unstructured":"Liu F, Yuan R, Benashski SE, McCullough LD. Changes in experimental stroke outcome across the lifespan. J Cereb Blood Flow Metab. Apr. 2009;29(4):792. https:\/\/doi.org\/10.1038\/JCBFM.2009.5.","DOI":"10.1038\/JCBFM.2009.5"},{"key":"767_CR30","doi-asserted-by":"publisher","unstructured":"Veszelka S et al. \u2018Effects of hydroxypropyl-beta-cyclodextrin on cultured brain endothelial cells\u2019, Molecules 2022, Vol. 27, Page 7738, vol. 27, no. 22, p. 7738, Nov. 2022. https:\/\/doi.org\/10.3390\/MOLECULES27227738","DOI":"10.3390\/MOLECULES27227738"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00767-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:58:45Z","timestamp":1771595925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00767-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00767-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7521331\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the University of Arizona Institutional Animal Care and Use Committee and conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}